Human mucosal T-cell cytotoxicity

Area of Science:

• Immunology
• Gastroenterology

Background:

• Antibody-triggered T-cell cytotoxicity (anti-CD3-T) is an indirect measure of in vivo primed cytotoxic T-cell activity.
• Investigating T-cell activity in the colonic mucosa is crucial for understanding gastrointestinal immune responses.

Purpose of the Study:

• To examine the lytic activity of freshly isolated T cells from noninflamed human colonic mucosa using anti-CD3-T triggering.
• To characterize the phenotype and functional properties of these mucosal T cells.

Main Methods:

• Isolation of T cells from human colonic mucosal specimens.
• Assessment of anti-CD3-triggered T-cell (anti-CD3-T) cytotoxicity.
• Analysis of surface antigen phenotype (CD2, CD3, CD8, CD4, CD16, Leu7) and Fc receptor expression.
• Evaluation of target cell specificity and inhibition by anti-CD45 antibody.

Main Results:

• Anti-CD3-T cytotoxicity was detected in all studied mucosal specimens.
• Mucosal anti-CD3-T effectors lack Fc receptors and are distinct from T gamma cells.
• The phenotype of mucosal anti-CD3-T cells is CD2+, CD3+, CD8+, CD4-, CD16-, Leu7-, differing from peripheral blood effectors (Leu7+).
• Mucosal anti-CD3-T cytotoxicity exhibits target specificity distinct from NK and LAK cells.
• CD45 molecule expression on effector cells appears to influence anti-CD3-T sensitivity.

Conclusions:

• Anti-CD3-T triggering is a valid method to assess cytotoxic T-cell activity in the human colonic mucosa.
• This technique may serve as a marker for in vivo primed mucosal T cells, potentially aiding in understanding inflammatory bowel disease pathogenesis where inciting antigens are uncertain.